药物对比
Rosiglitazone vs Tolbutamide
比较Rosiglitazone与Tolbutamide治疗2型糖尿病。Rosiglitazone（TZD）vs Tolbutamide（磺脲类）：改善胰岛素敏感性 vs 促进胰岛素分泌。副作用有所不同。
此页面暂无可用的对比维度。
临床背景
This comparison arises when considering alternative oral antidiabetics for type 2 diabetes patients inadequately managed on current therapy.
结论
Rosiglitazone and Tolbutamide are both viable options for type 2 diabetes, selected based on the patient's specific metabolic profile.
全部药物对比